Principal Financial Group’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
Principal Financial Group's STOK Position: Q3 2026 in Review
Principal Financial Group reduced its Stoke Therapeutics (STOK) stake by 88% in Q3 2026, selling an estimated $1.85M and leaving 8,624 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #2093.
Principal Financial Group first reported a position in STOK in Q3 2020 and has held it in 11 quarters since. The position peaked at $2.29M in Q2 2026. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- Principal Financial Group held 8,624 shares of Stoke Therapeutics worth $224K as of Q3 2026.
- Principal Financial Group sold 61,256 Stoke Therapeutics shares in Q3 2026, an estimated $1.85M.
- Stoke Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q3 2026, its #2093 holding.
- Principal Financial Group first reported a position in Stoke Therapeutics in Q3 2020 and has held it in 11 quarters since.
- Principal Financial Group's Stoke Therapeutics position peaked at $2.29M in Q2 2026.
- 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on Principal Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.